The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2,4-Dihydroxyphenyl)-2-(4-(furan-2-ylmethylene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)-4-methyl-N-(3-nitrophenyl)-1,6-dihydropyrimidine-5-carboxamide ID: ALA1087440
PubChem CID: 45276457
Max Phase: Preclinical
Molecular Formula: C27H22N6O7
Molecular Weight: 542.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1=NN(C2=NC(C)=C(C(=O)Nc3cccc([N+](=O)[O-])c3)C(c3ccc(O)cc3O)N2)C(=O)/C1=C/c1ccco1
Standard InChI: InChI=1S/C27H22N6O7/c1-14-21(13-19-7-4-10-40-19)26(37)32(31-14)27-28-15(2)23(24(30-27)20-9-8-18(34)12-22(20)35)25(36)29-16-5-3-6-17(11-16)33(38)39/h3-13,24,34-35H,1-2H3,(H,28,30)(H,29,36)/b21-13+
Standard InChI Key: DIVIUSUTSYDWGC-FYJGNVAPSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
-3.6833 -15.6476 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4833 -15.4309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9365 -16.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4167 -16.7703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6422 -16.4754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9637 -11.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9649 -12.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2501 -13.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5337 -12.7675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5366 -11.9371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2519 -11.5280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2484 -14.0037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9646 -14.4153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9651 -15.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2502 -15.6529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5334 -15.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5364 -14.4134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2543 -10.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6796 -13.1799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8176 -15.6463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8229 -13.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1075 -14.4098 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8250 -13.1742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6059 -13.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3193 -14.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0321 -13.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0305 -13.1709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3101 -12.7604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6002 -13.1763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3058 -11.9320 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5889 -11.5238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0176 -11.5152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7767 -14.6600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6323 -17.5666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7605 -16.1657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1371 -16.8997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9593 -17.0283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.0947 -17.8427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3538 -18.2192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7688 -17.6375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
16 20 1 0
5 1 1 0
17 21 1 0
10 11 2 0
21 22 1 0
11 6 1 0
21 23 2 0
1 2 1 0
22 24 1 0
24 25 2 0
12 13 1 0
25 26 1 0
6 7 2 0
26 27 2 0
13 14 1 0
27 28 1 0
2 3 1 0
28 29 2 0
29 24 1 0
14 15 2 0
7 8 1 0
15 16 1 0
30 31 2 0
30 32 1 0
28 30 1 0
14 1 1 0
3 4 1 0
2 33 2 0
16 17 2 0
4 34 1 0
17 12 1 0
3 35 2 0
8 12 1 0
35 36 1 0
36 37 1 0
8 9 2 0
11 18 1 0
4 5 2 0
7 19 1 0
37 38 1 0
38 39 2 0
39 40 1 0
40 36 2 0
M CHG 2 30 1 32 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 542.51Molecular Weight (Monoisotopic): 542.1550AlogP: 3.81#Rotatable Bonds: 5Polar Surface Area: 182.90Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.63CX Basic pKa: 0.76CX LogP: 3.17CX LogD: 3.15Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.21Np Likeness Score: -1.19
References 1. Ibrahim DA, El-Metwally AM.. (2010) Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors., 45 (3): [PMID:20045222 ] [10.1016/j.ejmech.2009.12.026 ]